Keyphrases
Niemann-Pick Disease Type B
100%
Niemann-Pick Disease
95%
Enzyme Replacement Therapy
47%
Acid Sphingomyelinase
47%
Lysosomal Storage Disease
23%
Delayed Puberty
14%
Recombinant Human Acid Sphingomyelinase
14%
Pharmacokinetics
11%
Clinical Trials
11%
Natural History
11%
Biochemical Studies
11%
Recombinant
11%
Disease Course
11%
Neurodegenerative Diseases
11%
Hepatosplenomegaly
11%
Multisystem Disease
11%
Growth Retardation
11%
Genotype
11%
Therapeutic Outcome
11%
FDA-approved Drugs
11%
Adulthood
11%
Pulmonary Disease
11%
Pharmacological Studies
11%
Family Planning
11%
Neurological Involvement
11%
Specific Intent
11%
Genotype-phenotype Correlation
11%
Neuronopathy
11%
Niemann-Pick
11%
Phase III Clinical Trial
11%
Disease Severity
11%
Gaucher Disease
11%
Prognostic Information
11%
Phenotypic Spectrum
11%
Bone Marrow Transplantation
11%
Therapeutic Effectiveness
11%
Medicine and Dentistry
Niemann-Pick Disease
95%
Acid Sphingomyelinase
31%
Enzyme Replacement Therapy
25%
Clinical Trial
12%
Lysosomal Storage Disease
12%
Storage Disease
12%
Gaucher Disease Type 1
7%
Silo-Filler's Disease
6%
Hepatosplenomegaly
6%
Cause of Death
6%
Disease Course
6%
Diagnosis
6%
Degenerative Disease
6%
Systemic Disease
6%
Disease Severity
6%
Genotype Phenotype Correlation
6%
Hyperlipidemia
6%
Bone Marrow Transplantation
6%
Growth Retardation
6%
Pharmacokinetics
6%
Delayed Puberty
6%
Infancy
6%
Family Planning
6%
Pharmacology, Toxicology and Pharmaceutical Science
Niemann Pick Disease
95%
Sphingomyelin Phosphodiesterase
31%
Replacement Therapy
25%
Storage Disease
12%
Lysosome Storage Disease
12%
Clinical Trial
12%
Gaucher Disease Type 1
7%
Delayed Puberty
7%
Degenerative Disease
6%
Disease Course
6%
Growth Retardation
6%
Hepatosplenomegaly
6%
Mouse
6%
Disease Severity
6%
Cause of Death
6%
Hyperlipidemia
6%
Systemic Disease
6%
Lung Disease
6%
Pharmacokinetics
6%